Table 3.
Overview of Results about Tissue Catechols in Patients with Parkinson’s Disease (PD), Mice with Very Low Activity of the Type 2 Vesicular Monoamine Transporter (VMAT2-Lo), and Mice with Knockouts of Aldehyde Dehydrogenase 1A1 and 2 Genes (ALDH1A1,2)
| Catechol | PD | VMAT2-Lo | ALDH1A1, 2 |
|---|---|---|---|
| DOPAL : DA | ↑ | ↓ | ↑ |
| DA : DOPA | ↓↓ | ↓↓ | ↔ |
| DOPAC : DOPAL | ↓ | ↑↑ | ↓↓ |
| DOPAC : DA | ↔ | ↑↑ | ↓ |
| DOPET : DOPAC | ↑↑ | ↓ | ↑↑ |
↑ Increased compared with controls.
↑↑↑ Markedly increased compared with controls (more than 5-fold).
↓ Decreased compared with controls.
↓↓ Markedly decreased compared with controls (less than 20%).
↔ Not significantly different from controls.